Targeted therapy in thyroid cancer: state of the art
L Valerio, L Pieruzzi, C Giani, L Agate, V Bottici… - Clinical oncology, 2017 - Elsevier
… thyroid cancer (DTC), medullary thyroid cancer (MTC) and possibly for cases of poorly
differentiated (PDTC) and anaplastic thyroid cancer (… and RAI-R thyroid cancers and some of them …
differentiated (PDTC) and anaplastic thyroid cancer (… and RAI-R thyroid cancers and some of them …
Differentiated thyroid cancer—treatment: state of the art
B Schmidbauer, K Menhart, D Hellwig… - International journal of …, 2017 - mdpi.com
… Differentiated thyroid cancer includes papillary and follicular cancer that … thyroid cancer
[4]. One study predicts that papillary thyroid cancer will become the third most expensive cancer …
[4]. One study predicts that papillary thyroid cancer will become the third most expensive cancer …
Diagnosis of thyroid cancer: state of art
M Boufraqech, D Patel, Y Xiong… - Expert opinion on …, 2013 - Taylor & Francis
… : Thyroid cancer is the most common endocrine cancer in the USA and its incidence is increasing
worldwide. Thyroid fine-… malignant and benign thyroid nodules. However, up to 30% of …
worldwide. Thyroid fine-… malignant and benign thyroid nodules. However, up to 30% of …
Surgical management of well-differentiated thyroid cancer: state of the art
J Suliburk, L Delbridge - Surgical Clinics, 2009 - surgical.theclinics.com
… The American Thyroid Association (ATA) guidelines for the management of thyroid
cancer were last published in 2006 and updated in 2009. They list several goals of therapy. …
cancer were last published in 2006 and updated in 2009. They list several goals of therapy. …
PET/CT in thyroid nodule and differentiated thyroid cancer patients. The evidence-based state of the art
A more conservative approach to the clinical management of thyroid nodules and differentiated
thyroid cancer has recently been proposed by the 2015 ATA guidelines. In this context, …
thyroid cancer has recently been proposed by the 2015 ATA guidelines. In this context, …
State of the art in the current management and future directions of targeted therapy for differentiated thyroid cancer
H Silaghi, V Lozovanu, CE Georgescu, C Pop… - International Journal of …, 2022 - mdpi.com
Two-thirds of differentiated thyroid cancer (DTC) patients with distant metastases would be
classified as radioactive iodine-refractory (RAIR-DTC), evolving into a poor outcome. Recent …
classified as radioactive iodine-refractory (RAIR-DTC), evolving into a poor outcome. Recent …
Animal models of medullary thyroid cancer: state of the art and view to the future
G Vitale, G Gaudenzi, L Circelli… - … -Related Cancer, 2017 - re.public.polimi.it
… approaches for cancer. Unfortunately, only few models are available for … thyroid carcinoma.
This review provides an overview of the state of the art of animal models in medullary thyroid …
This review provides an overview of the state of the art of animal models in medullary thyroid …
Lenvatinib in the therapy of aggressive thyroid cancer: state of the art and new perspectives with patents recently applied
SM Ferrari, I Ruffilli, M Centanni, C Virili… - … on Anti-Cancer Drug …, 2018 - ingentaconnect.com
… treated by the method of the present invention is a solid tumor, as thyroid cancer [71]. A
method for treating cancer (for example thyroid cancer) in a patient administering a combination …
method for treating cancer (for example thyroid cancer) in a patient administering a combination …
Genetic predisposition to familial nonmedullary thyroid cancer: an update of molecular findings and state‐of‐the‐art studies
E Bonora, G Tallini, G Romeo - Journal of oncology, 2010 - Wiley Online Library
… Familial thyroid cancer has become a well-recognized entity in patients with thyroid cancer
originating from follicular cells, that is, nonmedullary thyroid carcinoma. The diagnosis of …
originating from follicular cells, that is, nonmedullary thyroid carcinoma. The diagnosis of …
[HTML][HTML] Optimizing therapy for radioactive iodine-refractory differentiated thyroid cancer: current state of the art and future directions
R Dadu, ME Cabanillas - Minerva endocrinologica, 2012 - ncbi.nlm.nih.gov
… Thyroid cancer is the most common endocrine cancer. The estimated … thyroid cancer is
1,780 (780 male and 1,000 females). In women, thyroid cancer is the 5 th most common cancer, …
1,780 (780 male and 1,000 females). In women, thyroid cancer is the 5 th most common cancer, …
相关搜索
- differentiated thyroid cancer
- thyroid cancer targeted therapy
- familial nonmedullary thyroid cancer
- thyroid cancer surgical management
- thyroid cancer genetic predisposition
- aggressive thyroid cancer
- thyroid cancer patient selection
- thyroid cancer tyrosine kinase inhibitors
- thyroid cancer comprehensive review
- state of the art thyroid nodule
- treatment of advanced thyroid cancer
- thyroid cancer biomarkers
- pet ct in thyroid cancer
- lenvatinib for thyroid cancer
- radioactive iodine refractory thyroid cancer
- diagnosis of thyroid cancer